![Erling Jan-Olof Lundin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erling Jan-Olof Lundin
Président chez
Cellectricon AB
Profil
Erling Jan-Olof Lundin is currently the Chairman at Cellectricon AB, Principal at Eka Chemicals AB, and Principal at Berol Kemi AB. Previously, he served as the Non-Executive Chairman at Isogenica Ltd. from 2014 to 2019 and as a Director at Dunross & Co. AB. He holds a graduate degree from Chalmers University of Technology.
Postes actifs de Erling Jan-Olof Lundin
| Sociétés | Poste | Début |
|---|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Président | - |
Eka Chemicals AB
 Eka Chemicals AB Chemicals: SpecialtyProcess Industries Manufactures and sells chemicals for the pulp and paper industry | Corporate Officer/Principal | 17/01/2011 |
Berol Kemi AB | Corporate Officer/Principal | 17/01/2011 |
Anciens postes connus de Erling Jan-Olof Lundin
| Sociétés | Poste | Fin |
|---|---|---|
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Président | 31/12/2019 |
Dunross & Co. AB
 Dunross & Co. AB Investment ManagersFinance D&C is an active, value-oriented and highly focused investor. The firm's business concept consists in developing companies and turning them into successful businesses by acquiring significant portions of their capital and sometimes becoming active members of their management boards. The firm targets small growing companies from Sweden, Asia and Emerging Markets in which to invest with a long-term outlook. They follow a bottom-up process and select investment strategies, sectors and regions on a quarterly basis. D&C conducts in-house macroeconomic and microeconomic fundamental research with a view to analyze and evaluate companies focusing on their asset value, operating value and growth potential. They also use third-party research and make company visits to complement their research process. | Directeur/Membre du Conseil | - |
Formation de Erling Jan-Olof Lundin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Eka Chemicals AB
Eka Chemicals AB Chemicals: SpecialtyProcess Industries Manufactures and sells chemicals for the pulp and paper industry | Process Industries |
Dunross & Co. AB
Dunross & Co. AB Investment ManagersFinance D&C is an active, value-oriented and highly focused investor. The firm's business concept consists in developing companies and turning them into successful businesses by acquiring significant portions of their capital and sometimes becoming active members of their management boards. The firm targets small growing companies from Sweden, Asia and Emerging Markets in which to invest with a long-term outlook. They follow a bottom-up process and select investment strategies, sectors and regions on a quarterly basis. D&C conducts in-house macroeconomic and microeconomic fundamental research with a view to analyze and evaluate companies focusing on their asset value, operating value and growth potential. They also use third-party research and make company visits to complement their research process. | Finance |
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Berol Kemi AB |
